Levi Strauss & Co
NYSE:LEVI
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
12.42
24.66
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
LEVI
stock under the Base Case scenario is
21.35
USD.
Compared to the current market price of 22.27 USD,
Levi Strauss & Co
is
Overvalued by 4%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Levi Strauss & Co.
| FR |
|
LVMH Moet Hennessy Louis Vuitton SE
PAR:MC
|
|
| FR |
|
Hermes International SCA
PAR:RMS
|
|
| KR |
|
SBW
KRX:102280
|
|
| FR |
|
EssilorLuxottica SA
PAR:EL
|
|
| CH |
|
Compagnie Financiere Richemont SA
SIX:CFR
|
|
| FR |
|
Christian Dior SE
PAR:CDI
|
|
| FR |
|
Kering SA
PAR:KER
|
|
| IN |
|
Titan Company Ltd
NSE:TITAN
|
|
| DE |
|
Adidas AG
XETRA:ADS
|
|
| CN |
|
ANTA Sports Products Ltd
HKEX:2020
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Levi Strauss & Co
Balance Sheet Decomposition
Levi Strauss & Co
| Current Assets | 3B |
| Cash & Short-Term Investments | 707.5m |
| Receivables | 722.9m |
| Other Current Assets | 1.6B |
| Non-Current Assets | 3.6B |
| PP&E | 1.8B |
| Intangibles | 473.5m |
| Other Non-Current Assets | 1.4B |
| Current Liabilities | 2B |
| Accounts Payable | 621.4m |
| Accrued Liabilities | 1.2B |
| Short-Term Debt | 5.7m |
| Other Current Liabilities | 132.1m |
| Non-Current Liabilities | 2.5B |
| Long-Term Debt | 1B |
| Other Non-Current Liabilities | 1.5B |
Free Cash Flow Analysis
Levi Strauss & Co
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Levi Strauss & Co
|
Revenue
|
6.4B
USD
|
|
Cost of Revenue
|
-2.4B
USD
|
|
Gross Profit
|
3.9B
USD
|
|
Operating Expenses
|
-3.2B
USD
|
|
Operating Income
|
752.5m
USD
|
|
Other Expenses
|
-149.8m
USD
|
|
Net Income
|
602.7m
USD
|
LEVI Profitability Score
Profitability Due Diligence
Levi Strauss & Co's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
Levi Strauss & Co's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
LEVI Solvency Score
Solvency Due Diligence
Levi Strauss & Co's solvency score is 66/100. The higher the solvency score, the more solvent the company is.
Score
Levi Strauss & Co's solvency score is 66/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LEVI Price Targets Summary
Levi Strauss & Co
According to Wall Street analysts, the average 1-year price target for
LEVI
is 28.21 USD
with a low forecast of 23.23 USD and a high forecast of 34.65 USD.
Dividends
Current shareholder yield for
LEVI is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
LEVI
stock under the Base Case scenario is
21.35
USD.
Compared to the current market price of 22.27 USD,
Levi Strauss & Co
is
Overvalued by 4%.